Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-26

Clinical Trial Update: Risks of Ramadan Fasting in Patients With Primary Adrenal Insufficiency Treated With Prednisolone. [NA]

View source ↗

Summary

Clinical trial update highlighting the risks of Ramadan fasting in patients with primary adrenal insufficiency treated with prednisolone, including potential hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prednisolone (Prednisolone)

Snippet

Sponsor: Hopital La Rabta | Conditions: Primary Adrenal Insufficiency, Ramadan Fasting | NA | Status: NOT_YET_RECRUITING